Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Shares Out (Diluted) Over TimeExpanding
Percentile Rank100
3Y CAGR+599.3%
5Y CAGR+250.0%
Year-over-Year Change
Weighted average diluted shares outstanding
3Y CAGR
+599.3%/yr
vs +34.2%/yr prior
5Y CAGR
+250.0%/yr
Recent acceleration
Acceleration
+565.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
525.5x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 13404830.00 | +24.3% |
| 2024 | 10784037.00 | +3783.0% |
| 2023 | 277727.00 | +608.5% |
| 2022 | 39202.00 | +8.3% |
| 2021 | 36191.00 | +41.9% |
| 2020 | 25511.00 | +28.5% |
| 2019 | 19849.00 | +64.4% |
| 2018 | 12074.00 | +85.4% |
| 2017 | 6512.08 | +112.4% |
| 2016 | 3066.11 | - |